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Abstract 36 
 The present work describes a method based on solid-phase extraction (SPE) and 37 
ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) 38 
for the simultaneous determination of three quinolones (pipemidic acid, oxolinic acid 39 
and flumequine) and twelve fluoroquinolones (marbofloxacin, fleroxacin, pefloxacin, 40 
levofloxacin, norfloxacin, ciprofloxacin, enrofloxacin, danofloxacin, lomefloxacin, 41 
difloxacin, sarafloxacin, and moxifloxacin) in different infant and young children 42 
powdered milks. After suitable deproteination of the reconstituted powdered samples, a 43 
SPE procedure was developed providing recovery values higher than 84% (RSDs lower 44 
than 13%) for all the analytes, with limits of detection between 0.04 and 0.52 µg/kg. 45 
UPLC-MS/MS analyses were carried out in less than 10 minutes. Sixteen infant and 46 
young children powdered milk samples of different origin, type and composition bought 47 
at Spanish markets were analyzed. Residues of the selected antibiotics were not detected 48 
in any of the analyzed samples. 49 
 50 
Keywords: Quinolones, antibiotics, UPLC-MS/MS, SPE, powdered milk, infants 51 
 52 
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1. Introduction 53 
 During the last decade, special concern has arisen in the food safety field on 54 
infant foods, because infants’ low body weight makes them more vulnerable to food 55 
contaminants or residues (pesticides, pharmaceutical compounds, etc.). This fact is of 56 
special importance in infants up to two years old since they have a relative food intake 57 
that can be three times higher than that of adults. The wide variety of food products 58 
nowadays available, as well as the high number of target analytes to be analyzed in food 59 
monitoring programs, demands the development of ultra-fast analytical techniques able 60 
to provide results in a short time with extremely low detection limits to fulfill the 61 
requirements established by the current legislation. 62 
Infant foods are divided into infant formulae (usually for the first six months of 63 
life), follow-on formulae (when appropriate complementary feeding is introduced and 64 
indicated usually for babies between 6 and 12 months) and growth formulae according 65 
to the age of the children they are aimed at (usually babies older than one year). Their 66 
chemical composition is based on infants’ nutritional requirements and in most cases 67 
they are partly manufactured from bovine milk resulting in a powder that should be 68 
carefully reconstituted in boiled water. Nowadays, there is a relatively high number of 69 
infant powdered milk products with a variable composition commercially available 70 
worldwide. As a result of their bovine origin, it is of high importance to ensure that such 71 
products are free of veterinary drug residues like, for example, antibiotics that can 72 
develop resistance at this initial stage of life. In this sense, and with the aim of 73 
protecting infants’ health, the European Union (UE), has already established maximum 74 
residue limits (MRLs) for pesticides and mycotoxins in processed fruit, vegetables or 75 
cereal-based baby foods and infant formulae [1,2] because of the importance of both 76 
types of compounds. However, up to now, no legislation has been published regarding 77 
MRLs of pharmacologically active substances (including antibiotics) in such products, 78 
despite the fact that in the Commission Regulation 37/2010 [3] general MRLs are 79 
established for foodstuffs of animal origin. Even though, and concerning the analysis of 80 
antibiotics in infant and young children powdered milk, general MRLs established for 81 
bovine milk can be considered as a reference. 82 
Quinolones constitute an important family of antibiotics with a broad spectrum 83 
activity against Gram-positive and Gram-negative bacteria which are widespread used 84 
worldwide for the treatment of respiratory diseases and bacterial infections in humans 85 
and some food producing animals. In this last case, it is well known that their residues 86 
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can appear in foods of animal origin like meat, milk or its derivatives. [4-6]. Concerning 87 
EU MRLs of quinolones, only seven of them have been included in Commission 88 
Regulation 37/2010 [3]: danofloxacin (DANO), sarafloxacin (SARA), enrofloxacin 89 
(ENRO), flumequine (FLUME), marbofloxacin (MARBO), oxolinic acid (OXO) and 90 
difloxacin (DIFLO) which is a metabolite of SARA. However, SARA’s MRL has not 91 
been established in milk while DIFLO and OXO are forbidden in animals from which 92 
milk is produced for human consumption. MRLs for the other quinolones are 30 µg/kg 93 
for DANO, 100 µg/kg for ENRO expressed as sum of ENRO and ciprofloxacin 94 
(CIPRO, a metabolite of ENRO), 50 µg/kg for FLUME and 75 µg/kg for MARBO [3]. 95 
Up to now, very few articles have been published dealing with the analysis of 96 
antibiotics in baby foods [7-11], most of them [7-10] focusing on the analysis of some 97 
quinolones and fluoroquinolones (quinolones with a fluor atom in C-6 and a piperazinyl 98 
moiety in C-7). Such low number of works clearly indicates the need to develop suitable 99 
analytical approaches for this task at very low levels. As an example, Díaz-Álvarez et 100 
al. [8] analyzed nine quinolones (cinoxacin, nalidixic acid, enoxacin, OXO, FLUME, 101 
norfloxacin (NORFLO), ENRO, CIPRO and DANO) in baby foods based on chicken 102 
meat, vegetables, potatoes puree and olive oil. Rodríguez et al. [7] extracted five 103 
fluoroquinolones (CIPRO, ENRO, DANO, SARA and lomefloxacin (LOME) as 104 
internal standard) from infant milks and later extended this work to the determination of 105 
six fluoroquinolones (NORFLO, CIPRO, ENRO, DANO, SARA and LOME) in 106 
powdered milk-based infant formulae and poultry-based baby foods [9]. In all these 107 
cases, high-performance liquid chromatography (HPLC) was used either in combination 108 
with UV [8] or fluorescence detection [7, 9, 10] with MS/MS confirmation [7, 9]. Ultra-109 
performance liquid chromatography (UPLC) usually provides lower analysis time and 110 
higher efficiency and sensitivity compared to HPLC. UPLC has been previously used 111 
with success for the analysis of several small groups of quinolone antibiotics in milk 112 
[12-16] although no infant powdered milk products have been investigated so far 113 
applying a multiresidue method for the simultaneous determination of quinolones and 114 
fluoroquinolones. 115 
In this work, different quinolones, namely pipemidic acid (PIP), MARBO, 116 
fleroxacin (FLERO), levofloxacin (LEVO), pefloxacin (PEFLO), NORFLO, CIPRO, 117 
ENRO, DANO, LOME, DIFLO, SARA, moxifloxacin (MOXI), OXO and FLUME 118 
(Figure 1) are studied, including those for which the EU has established MRLs in milk. 119 
Thus, the aim of this contribution was to develop and apply a multiresidue method 120 
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based on the use of UPLC-MS/MS to simultaneously determine these antibiotics in 121 
different types of infant powdered milk products (infant, follow-on and growth 122 
formulae). 123 
 124 
2. Experimental 125 
2.1. Chemicals and samples 126 
All chemicals used were of analytical reagent grade. LOME hydrochloride, 127 
MARBO, CIPRO, DANO, ENRO, SARA hydrochloride, DIFLO hydrochloride, PIP, 128 
PEFLO mesylate dehydrate, FLERO, FLUME, and NORFLO were provided by Sigma 129 
Aldrich (Madrid, Spain). LEVO and OXO were obtained from Fluka (Madrid, Spain). 130 
MOXI was kindly supplied by Bayer HealthCare (Wuppertal, Germany). Quinolones 131 
were used without further purification (purity ≥98%). Individual standard solutions (100 132 
mg/L) were prepared in MeOH and kept in the dark under refrigeration at 4ºC. Mixtures 133 
of quinolones were prepared by appropriate combination and dilution with MeOH. 134 
Acetonitrile (ACN) and methanol (MeOH) were HPLC-grade from Lab-Scan 135 
(Gliwice, Sowinskiego, Poland) and distilled water was deionized by using a Milli-Q 136 
system (Millipore, Bedford, MA, USA). Acetic acid was purchased from Scharlau 137 
(Sentmenat, Spain), trichloroacetic acid (TCA) was from Merck (Darmstadt, Germany) 138 
and dehydrated ethylenediaminetetraacetic acid disodium salt (EDTA) and formic acid 139 
were from Sigma and Fluka, respectively.  140 
Infant formulae (for the first six months of life), follow-on formulae (indicated 141 
for babies between 6 and 12 months old) and growth formulae (for children above one 142 
year old) were bought in local supermarkets and chemists (Madrid, Spain). Samples 143 
were spiked with the selected antibiotics at several concentrations (see Results and 144 
Discussion section) in order to identify and quantify the analytes in the real samples. 145 
 146 
2.2. UPLC-MS/MS 147 
UPLC-MS/MS analyses were carried out using an Accela liquid chromatograph 148 
(Thermo Scientific, San Jose, CA) also equipped with a diode array detector (DAD) and 149 
an autosampler. The chromatograph was coupled to a TSQ Quantum (Thermo 150 
Scientific) triple quadrupole analyzer via an electrospray (ESI) interface. For data 151 
storage and evaluation the Xcalibur software (Thermo Scientific) was used. Analytical 152 
conditions employed consisted of the use of a Hypersil Gold C18 column (50 mm × 2.1 153 
mm and 1.9 µm of particle diameter) (Thermo Scientific) using 0.1% (v/v) formic acid 154 
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in Milli-Q water as mobile phase A and MeOH as mobile phase B. Elution was carried 155 
out according to the following gradient: 0 min, 10% B; 6 min, 40% B; 9 min, 50% B; 156 
9.1 min, 10% B; 13 min, 10% B. The optimum flow rate was 0.3 mL/min whereas the 157 
injection volume was 10 µL. The DAD recorded the spectra from 200 to 450 nm. 158 
Column and autosampler compartments were thermostated at 25ºC. 159 
To quantify the quinolones, the mass spectrometer was operated in the positive 160 
ESI mode. Spray voltage and capillary temperature were set at 3500 V and 250ºC, 161 
respectively. Nitrogen was used as sheath and auxiliary gas at pressures of 40 and 20 162 
arbitrary units, respectively. Ion sweep gas pressure was 2 units and collision gas (Ar) 163 
pressure, 1.5 mTorr. Scan width and the scan time were fixed at 0.020 (m/z) and 0.100 s 164 
and system was operated in selected reaction monitoring (SRM). SRM parameters were 165 
optimized by direct infusion of standards. Two transition ions were monitored for 166 
identification but only the most intense one for each precursor ion was used for 167 
quantification. The values corresponding to the tube lens offset voltage and collision 168 
energy for each selected ion transitions are indicated in Table 1. The StatGraphics Plus 169 
Software (Statistical Graphics, Rockville, USA) was used for data processing. 170 
 171 
2.3. Sample deproteination and SPE procedure 172 
Powdered milk samples were prepared according to manufacturers’ indications. 173 
SPE procedure was adapted from a method previously developed by our group to 174 
extract seven fluoroquinolones from bovine, ovine and caprine milk [17]. Briefly, 175 
reconstituted milk samples (2 mL) were spiked with the selected quinolones and 176 
deproteinated by mixing with 6 mL of ACN containing 20% w/v TCA and sonicated for 177 
30 min. Then, the mixture was kept in dark for 15 min and centrifuged for 15 min at 178 
4500 rpm. After suitable filtration of the supernatant with Chromafil Xtra PET-45/25 179 
filters of 0.45 µm pore size (Macherey-Nagel GmbH & Co. KG, Düren, Germany) the 180 
organic solvent was evaporated using a rotary evaporator R-200 equipped with a V-800 181 
vacuum controller and a V-500 vacuum pump (Büchi Labortechnik, Flawil, 182 
Switzerland). The residue was dissolved in water containing 11.24 g/L of EDTA. pH 183 
was adjusted to 4.0 with NaOH (1 M) and the sample was centrifuged again for 15 min 184 
at 4500 rpm. Then, the supernatant was subjected to a SPE procedure in a Vac-Master 185 
manifold (IST, Hengoed, South Wales, UK) using Oasis HLB cartridges (6 mL, 500 186 
mg) from Waters, previously activated with 5 mL of MeOH and 5 mL of Milli-Q water. 187 
When the retention step was completed, the cartridge was dried under vacuum of -10 188 
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mmHg (1 mmHg=133.322 Pa) for 20 min and elution of the retained antibiotics was 189 
carried out with 10 mL MeOH containing 1.5% (w/v) acetic acid. The eluate was then 190 
evaporated to dryness at 40ºC and 200 mbar. The dry residue was redissolved in 1 mL 191 
of MeOH and directly injected into the UPLC instrument. 192 
 Recovery values were assessed by comparing the peak areas obtained for 193 
standards spiked in milk samples before the extraction procedure with those obtained 194 
for standards spiked after the extraction step. In both cases, the samples did not contain 195 
the target analytes. 196 
 197 
3. Results and discussion 198 
3.1. UPLC-MS optimization 199 
The first step in the optimization of the separation of the selected antibiotics was 200 
the determination of the optimum UPLC separation parameters. To do that, a short C18 201 
chromatographic column was employed containing sub 2-µm particles (50 x 2.1 mm, 202 
1.9 µm particle diameter). The use of this kind of columns allows the attaining of fast 203 
separations with improved efficiencies compared to conventional columns [18]. 204 
According to the nature of the fifteen selected quinolones, different mobile phases were 205 
tested. Namely, water was employed containing 0.1-0.2 % v/v formic acid as mobile 206 
phase A whereas 100% methanol and 100% acetonitrile (both with and without 0.1% 207 
v/v formic acid) were tested as mobile phase B. The best results in terms of peak shapes 208 
and best signal-to-noise ratios in the positive ESI mode were provided by the 209 
combination of acidified water (0.1% v/v formic acid) and 100% methanol as mobile 210 
phases. Once these mobile phases were selected, the gradient of elution was adapted to 211 
maximize the separation among the interesting compounds while reducing the elution 212 
time. Temperature effect in the column compartment was studied between 25 and 40ºC 213 
to improve separation. However, although high temperature values could speed up the 214 
analyte elution, a decrease in the separation efficiency was observed at 40ºC. Thus, 215 
25ºC was selected for subsequent experiments. In section 2.2 the optimum separation 216 
parameters finally selected are described. Using these conditions, the separation of the 217 
15 compounds investigated was performed in less than 10 min. 218 
Once the UPLC separation was optimized, the different MS/MS detection 219 
parameters were studied. In this sense, the UPLC-MS/MS analysis of contaminants 220 
must fulfill the number of identification points required by the current EU legislation for 221 
the analysis of these components in foods [19]. In this work, two product ions for each 222 
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determined compound have been selected (from their corresponding precursor ions) 223 
which complies with the requirements proposed in this legislation. In this way, each 224 
compound is precisely characterized by its retention time as well as by two precursor-225 
product ion transitions. The most intense product ion was employed for quantification 226 
whereas the other one was used for peak identification. Although the selective detection 227 
of the antibiotics through the selection of appropriate ion transitions was optimized 228 
infusing directly those compounds into the MS instrument (see Table 1), the sensitivity 229 
of the analytical method might be significantly increased fine tuning the rest of 230 
ionization conditions. In this sense, the different parameters involved in the positive ESI 231 
of the antibiotics were studied, namely, capillary temperature (250-350ºC), spray 232 
voltage (3000-4500 V), sheath gas pressure (30-50 a.u.) and auxiliary gas pressure (0-5 233 
a.u.). The different parameters were optimized using a univariate method. The values 234 
which provided best total ion intensities were selected. The final detection and 235 
ionization conditions included the use of a capillary temperature of 250ºC, 3500 V in 236 
the spray voltage, and N2 pressures of 40 and 20 a.u. for the sheath and auxiliary gas, 237 
respectively, in the positive ESI mode.  238 
 239 
3.2. Intraday/interday precision and calibration studies. 240 
Once optimum separation conditions and MS/MS detection parameters were 241 
selected, instrumental intraday and interday precision was assessed. For this purpose, 242 
mixtures of the selected quinolones at two levels of concentration (between 20 µg/L and 243 
800 µg/L) were consecutively injected five times in the same day (n=5) and also in three 244 
different days (n=15). RSD values obtained in the same day were in the range between 245 
0.3% and 8.1% for peak areas and between 0.1% and 0.6% for retention times for the 246 
highest concentration level. Day-to-day RSD values were slightly higher in the range 247 
between 5.1% and 10.2% for peak areas and between 0.2% and 1.3% for retention 248 
times. Results obtained for the lowest concentration level were similar to the ones 249 
described above: RSD values obtained in the same day were in the range 2.4-10.1% for 250 
peak areas and 0.2-0.8% for retention times, while day-to-day RSD values were in the 251 
range 6.5-10.8% for peak areas and 0.4-1.6% for retention times. 252 
Besides, calibration curves were obtained by the triplicate injection of eight 253 
different concentration levels (n=8) (data not shown). Determination coefficients (R2) 254 
higher than 0.99 were obtained in all cases. Instrumental LODs values, which were 255 
calculated as three times the signal-to-noise (S/N) ratio, were lower than 1.06 µg/L 256 
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while instrumental LOQs values (calculated as ten times the S/N) were lower than 3.52 257 
µg/L. The obtained data demonstrated the suitability of the optimized UPLC-MS/MS 258 
for the fast and sensitive detection of the 15 studied quinolones in a single run. 259 
 260 
3.3. Optimization of the deproteination procedure. 261 
Samples investigated in this work have a protein and fat content in the range 10-262 
15% and 14-30%, respectively, and therefore, suitable protein precipitation and 263 
defattening of the samples is necessary. Initial experiments were carried out considering 264 
2 mL of a reconstituted infant formulae (as indicated by each manufacturer) and 265 
deproteination with 6 mL of 20% (w/v) TCA in MeOH. After suitable sonication, 266 
centrifugation and filtration, the supernatant was evaporated to dryness and redissolved 267 
in 50 mL of water containing 0.562 g of EDTA and adjusted to pH 4.0. Afterwards, the 268 
sample was passed through a previously activated Oasis HLB SPE cartridge of 500 mg. 269 
Addition of EDTA is necessary since the formation of complexes between these 270 
quinolones and EDTA clearly improves their SPE extraction with Oasis HLB cartridges 271 
[20]. After elution with 10 mL of MeOH containing 1.5% (w/v) of acetic acid, the 272 
evaporated sample was reconstituted in 1 mL MeOH and injected in the UPLC system. 273 
As indicated in the experimental section, recovery values were assessed by comparing 274 
the peak areas obtained for standards dissolved in the final sample matrix (free of the 275 
target quinolones) with those obtained for spiked samples. Under these conditions, 276 
mean recovery values of the selected quinolones were in the range 57-85%, which are 277 
clearly lower than our previous results obtained for the extraction of a reduced number 278 
of quinolones from raw milk which were between 73 and 113% (RSDs<16%) [17].  279 
Therefore, the extraction protocol had to be modified to improve the obtained 280 
results. To do that, several modifications of the deproteination conditions were carried 281 
out. For this purpose, higher amounts of MeOH and TCA percentages were used, as 282 
well as the use of ACN instead of MeOH, which has also shown to provide good results 283 
[13]. Besides, EDTA amount was also increased since our previous experience with the 284 
method clearly showed that depending of the calcium or magnesium content of the 285 
sample, competition of both cations for the EDTA may take place and therefore, higher 286 
amounts of the complexing agent might be necessary [20]. For comparison purposes, 287 
blank samples, which were found to be free of the selected analytes, were also analyzed. 288 
Figure 2 shows the recovery values obtained for each quinolone when some of the 289 
deproteination parameters as well as EDTA amount were changed. As it can be seen in 290 
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that Figure, a clear and comparable improvement in the recovery values were obtained 291 
(77-107 %) for two of the tested conditions, namely when 9 mL of MeOH containing 292 
20% (w/v) of TCA or 6 mL ACN containing 20% (w/v) TCA were used for the 293 
deproteination. These recoveries were also comparable to those attained in our previous 294 
work for raw milk [17]. As a result, and in order to minimize the volumes of organic 295 
solvent consumed, 6 mL of ACN containing 20% (w/v) TCA were used for subsequent 296 
experiments. The increase in the amount of EDTA did not improve the recovery values 297 
for any of the analyzed quinolones, being the initial amount (0.562g) enough to ensure a 298 
quantitative complexation for all analytes and, therefore, a suitable retention of the 299 
complexed analytes onto the SPE stationary phase. 300 
 301 
3.4. Matrix-matched calibration 302 
With the aim of verifying the influence of the sample matrix in the MS response, 303 
matrix effect of each sample type was studied by obtaining the calibration curves of the 304 
standards dissolved in methanol and in each of the three different sample matrices 305 
(using also methanol as solvent) at eight concentration levels. Each level was injected in 306 
triplicate in the UPLC-MS system. Table 2 shows matrix-matched calibration 307 
parameters including the regression equation (based on peak areas), the determination 308 
coefficient (R2) and standard deviation of the residuals (Sy/x) for the three types of 309 
matrices studied. Determination coefficients (R2) higher than 0.994 were obtained in all 310 
cases. Statistical comparison (calculation of F and p values) of matrix-matched 311 
calibration curves with the ones obtained in pure solvent was developed in order to 312 
evaluate if there is a change in the values of the intercepts or the slopes of the regression 313 
curves for each quinolone. If this happens, then there is a matrix effect for the 314 
compound under study and it would be necessary to develop a calibration in the sample 315 
matrix to get truthful results. In this sense, it could be clearly seen that a matrix effect 316 
occurred for almost all the quinolones. Besides, statistical comparison between matrix-317 
matched calibration curves revealed that there were also clear differences between them. 318 
Consequently, for quantification purposes matrix-matched calibration should be 319 
developed and applied for each sample type. 320 
 321 
3.5 Extraction recovery study. 322 
Once optimum SPE conditions were achieved, a recovery study was carried out 323 
at two levels of concentration for the three types of powdered milk samples (infant, 324 
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follow-on and growth formulae), with the aim of demonstrating the applicability of the 325 
method. Five replicates were carried out at each level. A previous extraction was 326 
developed for each sample in order to verify the absence of the selected quinolones. 327 
Results of the recovery study as well as the spiking levels are shown in Table 3. As it 328 
can be appreciated, recovery values were between 84 and 108% with RSDs values 329 
lower than 17% for infant formulae, between 98 and 117% with RSDs values lower 330 
than 11% for follow-on formulae and between 88 and 106% with RDSs lower than 9% 331 
for growth formulae. These results demonstrate the applicability of the developed 332 
method to extract quinolone residues from different types of powdered milk samples 333 
devoted to infants’ consumption, independently on their fat, protein and carbohydrate 334 
contents. LODs and LOQs of the method obtained for the reconstituted samples were in 335 
the range 0.04-0.54 µg/L and 0.14-1.80 µg/L, respectively. Considering the sample 336 
weight, LOD values were between 0.04 and 0.52 µg/kg, while LOQ values were 337 
between 0.13 and 1.73 µg/kg. They were calculated as the lowest analyte concentration 338 
in the real sample that provided a signal-to-noise ratio of 3 and 10, respectively. Such 339 
quantification limits are well below EU MRLs already established for some of these 340 
compounds (30–100 µg/kg) in bovine raw milk [3], which can be taken as a reference, 341 
although, as previously indicated, there is no current legislation regarding MRLs for 342 
quinolones in this type of samples. Figure 3 shows the UPLC-MS/MS chromatograms 343 
of a spiked powdered milk (growth formula) after the deproteination and SPE 344 
procedure. As it can be deduced from the figure, the selected quinolones can be 345 
perfectly identified and quantified in such complex samples, since clean extracts can be 346 
observed without interferences. Furthermore, it can be noted that, although complete 347 
resolution is not obtained for some of the quinolones, MS/MS allows the selective 348 
determination of these compounds since unique transitions are monitored. Similar 349 
chromatograms were obtained for the other two types of samples. 350 
 Concerning previous works dealing with the analysis of some of these 351 
quinolones in baby foods, LOQs reached in our work are lower than those previously 352 
obtained for the analysis of CIPRO, ENRO, DANO, SARA and LOME (as internal 353 
standard) by SPE-HPLC-FD (LOQs of 6-80 µg/kg) [7] as well as lower than those 354 
attained after the pressurized liquid extraction and HPLC-FD analysis of NORFLO, 355 
CIPRO, ENRO, DANO, SARA and LOME (LOQs of 12-22 µg/kg) in powdered infant 356 
formulae [9]. 357 
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As it has been already stated, this is the first time that UPLC-MS/MS is 358 
employed for the analysis of quinolone residues in infant powdered milk. Nevertheless, 359 
the obtained LODs are comparable to those attained in previous UPLC-MS/MS-based 360 
applications for the analysis of quinolones in raw milk samples [14] and lower than the 361 
ones obtained by QuEChERS-UPLC-QqQ-MS [12, 16] and by ultrafiltration-UPLC-362 
TOF-MS [13]. 363 
 364 
3.6. Powdered milk samples analysis 365 
 In order to fully demonstrate the applicability of the proposed method, 16 366 
samples of different type, origin and composition commercialized in Spain were 367 
analyzed. Samples included five infant formulae, eight follow-on formulae and three 368 
growth formulae (one of them with cereals). None of the analyzed samples presented 369 
any detectable residues of the selected quinolones in good agreement with previous 370 
works in which a more reduced number of quinolones were analyzed in similar samples 371 
[7, 9]. 372 
 373 
4. Conclusions 374 
In this work, the combined use of SPE and UPLC-MS/MS is proposed for the 375 
simultaneous and rapid analysis of 15 quinolones in infant powdered milk of different 376 
type, origin and composition. The method, which involves a previous deproteination of 377 
the samples with ACN containing 20% (w/v) of TCA, is highly sensitive (LODs below 378 
0.52 µg/kg for the reconstituted samples), repeatable and selective, with high recovery 379 
values (>84%). The analysis of 16 commercialized powdered milk samples (infant, 380 
follow-on and growth formulae) revealed the absence of these compounds in all the 381 
samples. 382 
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Figure captions 430 
 431 
Figure 1.- Structures, acronyms and monoisotopic molecular weight of the selected 432 
quinolones. 433 
 434 
Figure 2.- Effect of deproteination conditions on the recovery values of the selected 435 
quinolones: (1) 6 mL MeOH 20% TCA, (2) 6 mL MeOH 30% TCA, (3) 9 mL MeOH 436 
20% TCA, (4) 6 mL ACN 20% TCA; and (5) effect of the addition of a higher amount 437 
of EDTA (0.750 g) on the recoveries (in this case 6 mL MeOH 20% TCA were used for 438 
deproteination of the sample). See experimental section for details. 439 
 440 
Figure 3.- UPLC-MS/MS chromatogram of a growth powdered milk spiked at 400 441 
µg/L with the studied quinolones. 442 
 443 
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Table 1.- Retention times and MS/MS detection parameters for the selected quinolones. 444 
 445 
Peak Antibiotic tR (min) Precursor ion 
(m/z) [M-+H]+ 
SRM transitions Tube lens offset 
(V) Quantifier ion (m/z) 
(Collision energy, V) 
Qualifier ion (m/z) 
(Collision energy, V) 
1 PIP 3.36 304.1 217.1 (21) 189.0 (31) 87 
2 MARBO 3.69 363.1 320.0 (12) 276.2 (13) 94 
3 FLERO 3.83 370.1 326.1 (17) 269.1 (27) 93 
4 LEVO 4.21 362.1 318.1 (19) 261.1 (26) 92 
5 PEFLO 4.24 334.1 290.2 (17) 233.1 (25) 86 
6 NORFLO 4.42 320.1 302.1 (20) 276.1 (15) 88 
7 CIPRO 4.63 332.1 314.2 (21) 288.1 (15) 85 
8 ENRO 4.77 360.2 316.1 (18) 245.1 (25) 93 
9 DANO 4.85 358.1 340.2 (23) 314.1 (19) 91 
10 LOME 4.90 352.1 265.1 (22) 308.1 (22) 90 
11 DIFLO 5.20 400.2 356.1 (20) 299.0 (28) 94 
12 SARA 5.45 386.1 342.1 (16) 299.0 (21) 97 
13 MOXI 6.56 402.2 384.1 (23) 261.0 (22) 97 
14 OXO 6.89 262.1 244.0 (20) 130.2 (35) 84 
15 FLUME 9.07 262.1 244.1 (16) 202.0 (32) 85 
446 
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Table 2.-Matrix matched calibration data of the selected quinolones. 447 
Peak Antibiotic Matrix Range of concentration tested (µg/L) Slope (n=8) Intercept (n=8) R2 Sy/x 
1 PIP 
Infant powdered milk 
1.0-1200 
(1.00±0.05) 104 (6.19±28.1) 104 0.998 2.08·105 
Follow-on powdered milk (9.98±0.50) 103 (5.79±3.08) 105 0.999 1.99·105 
Growth powdered milk (1.29±0.06) 104 (3.65±31.6) 104 0.999 2.53·105 
2 MARBO 
Infant powdered milk 
1.5-1200 
(3.74±0.41) 103 (2.03±26.2) 104 0.999 8.94·104 
Follow-on powdered milk (4.04±0.28) 103 (1.58±1.72) 105 0.998 1.10·105 
Growth powdered milk (5.27±0.21) 103 (-7.91±119) 103 0.999 9.44·104 
3 FLERO 
Infant powdered milk 
1.5-1200 
(2.59±0.06) 104 (-1.72±28.6) 104 1.000 2.09·105 
Follow-on powdered milk (2.39±0.12) 104 (1.01±0.71) 106 0.999 4.56·105 
Growth powdered milk (3.06±0.09) 104 (1.35±5.14) 105 0.999 4.07·105 
4 LEVO 
Infant powdered milk 
1.0-1200 
(2.33±0.10) 104 (2.19±5.18) 105 0.999 3.83·105 
Follow-on powdered milk (2.53±0.21) 104 (1.02±1.29) 106 0.996 8.38·105 
Growth powdered milk (3.28±0.10) 104 (1.20±5.45) 105 0.999 4.37·105 
5 PEFLO 
Infant powdered milk 
2.0-1200 
(1.12±0.14) 104 (2.15±7.77) 105 0.996 4.26·105 
Follow-on powdered milk (1.28±0.06) 104 (4.30±3.42) 105 0.999 2.15·105 
Growth powdered milk (1.49±0.04) 104 (1.36±2.38) 105 0.999 1.86·105 
6 NORFLO 
Infant powdered milk 
5.0-1200 
(2.57±0.08) 104 (3.21±45.9) 104 1.000 2.59·105 
Follow-on powdered milk (2.84±0.17) 104 (1.56±1.09) 106 0.998 6.26·105 
Growth powdered milk (3.50±0.16) 104 (-1.77±9.51) 105 0.998 6.94·105 
7 CIPRO 
Infant powdered milk 
2.0-1200 
(2.99±0.18) 104 (-1.84±9.32) 105 0.998 6.74·105 
Follow-on powdered milk (3.19±0.20) 104 (9.26±12.2) 105 0.998 7.70·105 
Growth powdered milk (3.79±0.13) 104 (-9.43±71.5) 104 0.999 5.59·105 
8 ENRO 
Infant powdered milk 
2.0-1200 
(2.58±0.15) 104 (1.85±7.96) 105 0.998 5.76·105 
Follow-on powdered milk (3.04±0.17) 104 (8.49±10.3) 105 0.998 6.49·105 
Growth powdered milk (3.58±0.14) 104 (5.54±78.5) 104 0.999 6.14·105 
9 DANO 
Infant powdered milk 
2.0-1200 
(2.20±0.12) 104 (1.77±6.36) 105 0.998 4.60·105 
Follow-on powdered milk (2.43±0.16) 104 (6.52±9.57) 105 0.998 6.02·105 
Growth powdered milk (2.98±0.16) 104 (-2.92±8.86) 105 0.998 6.93·105 
10 LOME 
Infant powdered milk 
1.5-1200 
(2.18±0.09) 104 (1.73±4.54) 105 0.999 3.32·105 
Follow-on powdered milk (2.95±0.25) 104 (1.48±1.51) 106 0.996 9.65·105 
Growth powdered milk (3.47±0.09) 104 (4.72±4.92) 105 1.000 3.89·105 
11 DIFLO 
Infant powdered milk 
3.0-1200 
(1.74±0.05) 104 (5.56±30.8) 104 1.000 1.73·105 
Follow-on powdered milk (2.24±0.09) 104 (6.81±5.37) 105 0.999 3.28·105 
Growth powdered milk (2.75±0.16) 104 (-7.70±89.4) 104 0.998 6.83·105 
12 SARA 
Infant powdered milk 
5.0-1200 
(9.82±0.84) 103 (-1.14±4.48) 105 0.996 3.03·105 
Follow-on powdered milk (1.02±0.05) 104 (5.80±3.27) 105 0.999 1.88·105 
Growth powdered milk (1.22±0.02) 104 (6.71±11.7) 104 1.000 8.56·104 
13 MOXI 
Infant powdered milk 
3.0-1200 
(1.82±0.15) 104 (-4.11±9.01) 105 0.997 5.62·105 
Follow-on powdered milk (1.15±0.27) 104 (5.33±5.90) 105 0.994 1.80·105 
Growth powdered milk (2.41±0.10) 104 (-4.30±5.67) 105 0.999 4.33·105 
14 OXO 
Infant powdered milk 
6.0-1200 
(6.52±0.85) 104 (3.42±4.84) 106 0.995 2.65·106 
Follow-on powdered milk (7.600±0.72) 104 (7.16±4.87) 106 0.997 2.19·106 
Growth powdered milk (6.84±0.68) 104 (2.57±4.53) 106 0.997 2.15·106 
15 FLUME 
Infant powdered milk 
2.0-1200 
(3.43±0.11) 105 (1.46±5.65) 106 0.999 4.09·106 
Follow-on powdered milk (3.17±0.05) 105 (-1.71±2.98) 106 1.000 1.87·106 
Growth powdered milk (2.76±0.04) 105 (3.99±21.5) 105 1.000 1.68·106 
448 
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Table 3.- Mean recovery percentages (n=5), RSDs (between parenthesis in italics), spiked concentration (between parenthesis in bold), LOD and 449 
LOQ values of method. 450 
 451 
Peak Antibiotic 
Infant powdered milk 
LOD 
method 
(µg/kg) 
LOQ 
method 
(µg/kg) 
Follow-on powdered milk 
LOD 
method 
(µg/kg) 
LOQ 
method 
(µg/kg) 
Growth powdered milk 
LOD 
method 
(µg/kg) 
LOQ 
method 
(µg/kg) 
Level 1, 
recoverya 
(%RSD) 
(added µg/L) 
Level 2, 
recoverya 
(%RSD) 
(added µg/L) 
Level 1, 
recoverya 
(%RSD) 
(added µg/L) 
Level 2, 
recoverya 
(%RSD) 
(added µg/L) 
Level 1, 
recoverya 
(%RSD) 
(added µg/L) 
Level 2, 
recoverya 
(%RSD) 
(added µg/L) 
1 PIP 95 (17) (10) 92 (6) (400) 0.05 0.16 109 (4) (10) 110 (4) (400) 0.04 0.13 88 (9) (10) 99 (6) (400) 0.05 0.15 
2 MARBO 95 (15) (15) 106 (5) (400) 0.09 0.31 106 (9) (15) 111 (8) (400) 0.09 0.29 98 (9) (15) 98 (7) (400) 0.10 0.32 
3 FLERO 88 (15) (15) 93 (8) (400) 0.11 0.36 104 (9) (15) 117 (6) (400) 0.09 0.29 94 (5) (15) 94 (6) (400) 0.10 0.35 
4 LEVO 89 (13) (10) 86 (7) (400) 0.06 0.22 109 (4) (10) 114 (7) (400) 0.05 0.17 95 (5) (10) 102 (8) (400) 0.06 0.19 
5 PEFLO 91 (11) (20) 95 (7) (400) 0.19 0.64 110 (8) (20) 114 (9) (400) 0.16 0.53 94 (5) (20) 106 (7) (400) 0.18 0.59 
6 NORFLO 97 (12) (50) 97 (13) (400) 0.32 1.07 110 (6) (50) 114 (6) (400) 0.28 0.93 89 (6) (50) 103 (5) (400) 0.33 1.08 
7 CIPRO 98 (14) (20) 90 (9) (400) 0.16 0.53 111 (5) (20) 110 (7) (400) 0.14 0.45 90 (5) (20) 104 (5) (400) 0.15 0.51 
8 ENRO 94 (9) (20) 91 (6) (400) 0.19 0.64 109 (4) (20) 105 (7) (400) 0.17 0.56 97 (7) (20) 95 (6) (400) 0.19 0.62 
9 DANO 87 (10) (20) 89 (3) (400) 0.17 0.56 111 (3) (20) 118 (7) (400) 0.13 0.44 95 (8) (20) 102 (7) (400) 0.15 0.50 
10 LOME 92 (15) (15) 87 (10) (400) 0.12 0.38 112 (6) (15) 117 (6) (400) 0.09 0.30 101 (5) (15) 102 (8) (400) 0.10 0.34 
11 DIFLO 89 (5) (30) 89 (7) (400) 0.24 0.79 117 (4) (30) 114 (6) (400) 0.18 0.61 101 (7) (30) 103 (3) (400) 0.21 0.69 
12 SARA 97 (11) (50) 91 (3) (400) 0.31 1.02 116 (4) (50) 117 (8) (400) 0.25 0.82 99 (8) (50) 97 (6) (400) 0.29 0.97 
13 MOXI 94 (14) (30) 84 (5) (400) 0.23 0.78 108 (7) (30) 100 (8) (400) 0.20 0.67 98 (9) (30) 101 (4) (400) 0.21 0.70 
14 OXO 94 (8) (60) 108 (8) (400) 0.51 1.69 98 (3) (60) 109 (11) (400) 0.49 1.65 99 (3) (60) 97 (6) (400) 0.52 1.74 
15 FLUME 94 (3) (20) 96 (1) (400) 0.15 0.51 98 (6) (20) 98 (4) (400) 0.15 0.49 101 (2) (20) 100 (1) (400) 0.14 0.48 
a Mean of five extractions (n=5). 452 
 453 
